Foresite Capital Management V as of March 31, 2022
Portfolio Holdings for Foresite Capital Management V
Foresite Capital Management V holds 17 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pardes Biosciences | 27.7 | $68M | 9.4M | 7.22 | |
| Theseus Pharmaceuticals | 15.1 | $37M | 3.2M | 11.53 | |
| Somalogic Com Cl A | 12.2 | $30M | 3.7M | 8.02 | |
| Aclaris Therapeutics (ACRS) | 8.9 | $22M | 1.3M | 17.24 | |
| Hims & Hers Health Com Cl A (HIMS) | 5.9 | $14M | 2.7M | 5.33 | |
| Adicet Bio (ACET) | 5.5 | $14M | 680k | 19.97 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 4.5 | $11M | 2.3M | 4.68 | |
| Cullinan Oncology (CGEM) | 4.2 | $10M | 993k | 10.47 | |
| Kinnate Biopharma | 4.0 | $9.9M | 875k | 11.26 | |
| Adagio Therapeutics (IVVD) | 2.7 | $6.5M | 1.4M | 4.56 | |
| Compass Therapeutics (CMPX) | 2.5 | $6.0M | 4.4M | 1.37 | |
| Research Alliance Corp. II Com Cl A | 2.0 | $4.9M | 500k | 9.76 | |
| Gemini Therapeutics | 1.4 | $3.4M | 2.4M | 1.39 | |
| Cue Health (HLTHQ) | 1.3 | $3.2M | 491k | 6.45 | |
| Enanta Pharmaceuticals (ENTA) | 1.2 | $3.0M | 42k | 71.17 | |
| 23andMe Holding Com Cl A (ME) | 0.6 | $1.6M | 407k | 3.83 | |
| Pharvaris N V (PHVS) | 0.3 | $619k | 34k | 18.13 |
